Toolkit/Optopatch

Optopatch

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

The web research summary states that the anchor paper explicitly names Optopatch as the coexpression vector/platform enabling cross-talk-free genetically targeted all-optical electrophysiology.

Usefulness & Problems

No literature-backed usefulness or problem-fit explainer has been materialized for this record yet.

Published Workflows

Objective: Enable all-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins for optical stimulation and optical voltage recording in the same genetically targeted system.

Why it works: The source scaffold indicates that the platform pairs QuasAr voltage indicators with the CheRiff actuator and emphasizes spectral orthogonality and cross-talk-free operation.

microbial rhodopsin-based voltage-sensitive fluorescencechannelrhodopsin-based optical actuationall-optical electrophysiologycoexpression platform design

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A composed arrangement of multiple parts that instantiates one or more mechanisms.

Target processes

recombinationselection

Input: Light

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1application scopesupports2017Source 2needs review

The review discusses bPAC as an optogenetic tool for cAMP control.

Claim 2application scopesupports2017Source 2needs review

The review discusses iGluSnFR as a neurotransmitter reporter relevant to synaptic function assays.

Claim 3application scopesupports2017Source 2needs review

The review discusses optoXRs as optogenetic tools for GPCR signaling in discovery-oriented applications.

Claim 4component compositionsupports2017Source 2needs review

The review describes Optopatch as pairing CheRiff with QuasAr voltage indicators.

Claim 5review scopesupports2017Source 2needs review

This review centers optogenetic and all-optical electrophysiology approaches for phenotypic screening in drug discovery.

Claim 6tool applicationsupports2016Source 3needs review

GCaMP6s is used in the review context as an activity reporter example for zebrafish brain imaging.

The anchor figure caption explicitly cites GCaMP6s for zebrafish brain activity imaging.
Claim 7tool applicationsupports2016Source 3needs review

LOVpep and ePDZ are presented in the review context as a light-induced intracellular trafficking control system.

The anchor figure caption names LOVpep and ePDZ in a light-induced trafficking example.
Claim 8tool composition or rolesupports2016Source 3needs review

Optopatch is presented in the review context as an all-optical electrophysiology system with CheRiff and QuasAr2 as named components.

PubMed figure captions ... explicitly mention tool/component names used in the review, especially Optopatch/CheRiff/QuasAr2.
Claim 9tool mechanismsupports2016Source 3needs review

pMag and nMag are presented in the review context as a light-induced dimerization pair used to reconstitute split Cas9 in photoactivatable genome editing.

The anchor figure caption names pMag as one half of the light-induced dimerization pair used to reconstitute split Cas9 ... nMag as the partner to pMag.
Claim 10component rolesupports2014Source 1needs review

CheRiff is an engineered channelrhodopsin actuator that is spectrally orthogonal to QuasAr indicators.

Claim 11component rolesupports2014Source 1needs review

QuasAr1 and QuasAr2 are evolved archaerhodopsin-based voltage indicators named as core components of the anchor paper.

Claim 12system capabilitysupports2014Source 1needs review

Optopatch is a coexpression platform enabling cross-talk-free genetically targeted all-optical electrophysiology.

Claim 13tool introductionsupports2014Source 1needs review

This paper presents all-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins.

Approval Evidence

3 sources5 linked approval claimsfirst-pass slug optopatch
The review explicitly centers optogenetic/all-optical electrophysiology for phenotypic screening, especially the Optopatch platform pairing CheRiff with QuasAr voltage indicators.

Source:

The supplied web research summary states that PubMed figure captions for the anchor review explicitly mention Optopatch and that the review spans all-optical electrophysiology.

Source:

The web research summary states that the anchor paper explicitly names Optopatch as the coexpression vector/platform enabling cross-talk-free genetically targeted all-optical electrophysiology.

Source:

component compositionsupports

The review describes Optopatch as pairing CheRiff with QuasAr voltage indicators.

Source:

review scopesupports

This review centers optogenetic and all-optical electrophysiology approaches for phenotypic screening in drug discovery.

Source:

tool composition or rolesupports

Optopatch is presented in the review context as an all-optical electrophysiology system with CheRiff and QuasAr2 as named components.

PubMed figure captions ... explicitly mention tool/component names used in the review, especially Optopatch/CheRiff/QuasAr2.

Source:

system capabilitysupports

Optopatch is a coexpression platform enabling cross-talk-free genetically targeted all-optical electrophysiology.

Source:

tool introductionsupports

This paper presents all-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins.

Source:

Comparisons

No literature-backed comparison notes have been materialized for this record yet.

Ranked Citations

  1. 1.
    StructuralSource 1Nature Methods2014Claim 10Claim 11Claim 12

    Seeded from load plan for claim claim_1. Extracted from this source document.

  2. 2.
    StructuralSource 2Trends in biotechnology2017Claim 1Claim 2Claim 3

    Seeded from load plan for claim clm_1. Extracted from this source document.

  3. 3.
    StructuralSource 3Biophysical Journal2016Claim 6Claim 7Claim 8

    Extracted from this source document.